Foundation for Innovative New Diagnostics-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Foundation for Innovative New Diagnostics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014016
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured project management framework, product development services, buruli ulcer diagnosis, chagas disease diagnostic solutions, hat diagnostic solutions, and tuberclosis diagnostic solutions. FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions. The organization has its presence in Switzerland, India, Uganda, and South Africa. FIND is headquartered in Geneva, Switzerland.

Foundation for Innovative New Diagnostics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Foundation for Innovative New Diagnostics, Medical Devices Deals, 2011 to YTD 2017 9
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Janssen Pharma Enters into Agreement with Foundation for Innovative New Diagnostics 11
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Foundation for Innovative New Diagnostics – Key Competitors 14
Foundation for Innovative New Diagnostics – Key Employees 15
Foundation for Innovative New Diagnostics – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Key Facts 2
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Foundation for Innovative New Diagnostics, Deals By Therapy Area, 2011 to YTD 2017 8
Foundation for Innovative New Diagnostics, Medical Devices Deals, 2011 to YTD 2017 9
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Janssen Pharma Enters into Agreement with Foundation for Innovative New Diagnostics 11
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Foundation for Innovative New Diagnostics, Key Competitors 14
Foundation for Innovative New Diagnostics, Key Employees 15
Foundation for Innovative New Diagnostics, Other Locations 16

★海外企業調査レポート[Foundation for Innovative New Diagnostics-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hitachi Ltd (6501)-エネルギー分野:企業M&A・提携分析
    Summary Hitachi, Ltd. (Hitachi) is a multinational company with operations in sectors such as engineering and electronics, nuclear, transportation and industrial systems. It manufactures and sells information and telecommunication systems, power systems, social infrastructure and industrial systems, …
  • Graphic Packaging Holding Company:戦略・SWOT・企業財務分析
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nymox Pharmaceutical Corp (NYMX)-医療機器分野:企業M&A・提携分析
    Summary Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the …
  • Public Gas Corporation SA:企業の戦略的SWOT分析
    Public Gas Corporation SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mr. Price Group Ltd.
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Stada Arzneimittel AG (SAZ):医療機器:M&Aディール及び事業提携情報
    Summary Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers a portfolio of product …
  • Eni SpA (ENI):石油・ガス:M&Aディール及び事業提携情報
    Summary Eni SpA (Eni) is an integrated oil and gas company that carries out oil and natural gas exploration, field development and production activities. It is also involved in supply, trading and shipping of natural gas, LNG, electricity and fuels. The company has operations in Italy, Cyprus, the U …
  • Chimerix Inc (CMRX):企業の財務・戦略的SWOT分析
    Summary Chimerix Inc (Chimerix) is a biopharmaceutical company that develops, discovers, and commercializes novel and oral antiviral therapeutics. The company’s brincidofovir is an oral nucleotide analog to treat dsDNA viruses, adenovirus, cytomegalovirus, BK virus and herpes simplex viruses. Chimer …
  • JinkoSolar Holding Co Ltd (JKS):電力:M&Aディール及び事業提携情報
    Summary JinkoSolar Holding Co Ltd (JinkoSolar) is a manufacturer of solar products. The company is involved in manufacturing and marketing of solar power products such as silicon ingots, silicon wafers, solar modules, solar PV cells, and monocrystalline and multicrystalline photovoltaic (PV) panels. …
  • Dermapharm AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Dermapharm AG (Dermapharm) is a pharmaceutical company that offers dermatological and allergy medicines. The company offers products for allergies, disinfection and wound treatment, skin and hair care, corticoids, minerals, osteoporosis, fungal infections, vaginal thrush, other preparations, …
  • Repsol Sinopec Resources UK Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Repsol Sinopec Resources UK Ltd (Repsol Sinopec), formerly Talisman Sinopec Energy UK Ltd is an oil and gas company that offers exploration services. The company explores, discovers, and produces oil and gas across the North Sea. It provides operation in floating facilities, offshore platfor …
  • OPG Power Ventures Plc (OPG):企業の財務・戦略的SWOT分析
    OPG Power Ventures Plc (OPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Mercy Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Mercy Health, formerly Catholic Healthcare Partners, is a Catholic non-profit health system. It operates through a network of hospitals, clinics, medical centers and urgent care facilities in Ohio and Kentucky to offer healthcare services across various specialties. Mercy Health also provide …
  • Torm Plc (TRMD A):企業の財務・戦略的SWOT分析
    Torm Plc (TRMD A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • YaSheng Group Ltd (HERB):企業の財務・戦略的SWOT分析
    Summary YaSheng Group Ltd (YaSheng) is a manufacturer of agriculture and package based products. The company operates through livestock, agriculture and biotechnology segments. YaSheng cultivates, processes, markets and distributes various food and agro-by products including field crops, fruits, veg …
  • TS Corp (001790):企業の財務・戦略的SWOT分析
    TS Corp (001790) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PT Telekomunikasi Indonesia Tbk (TLKM):企業の財務・戦略的SWOT分析
    PT Telekomunikasi Indonesia Tbk (TLKM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • 3D Systems Corporation:戦略・SWOT・企業財務分析
    3D Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary 3D Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MTR Corporation Ltd:企業の戦略・SWOT・財務情報
    MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • United National Breweries (SA) (Pty) Limited:企業の戦略・SWOT・財務分析
    United National Breweries (SA) (Pty) Limited - Strategy, SWOT and Corporate Finance Report Summary United National Breweries (SA) (Pty) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆